Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
11 Sep 2024 - Linius Technologies Limited (ASX:LNU) CEO James Brennan discusses the company's recent capital raise, partnerships with Prime Focus, Magnify and Avid, and the launch of Captivate, a platform that enables broadcasters to offer personalised video content and compete with social media giants like TikTok and YouTube.
19 Jun 2023 - Industry standard graphite anodes have reached their technical limitations. AnteoTech Limited (ASX:ADO) CEO and Managing Director David Radford discusses the company's solution for significantly increasing battery capacity by enhancing silicon integration.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
19 Feb 2020 - BluGlass (ASX:BLG) Managing Director, Giles Bourne talks about the opportunities that laser diodes represent for the company, following the Photonics West Conference.
29 07 2024 - David Flanagan - Managing Director - Arrow Minerals (ASX:AMD) is actively exploring the Simandou North Iron Project (SNIP) in Guinea, West Africa with the intention of discovering and developing a direct shipping grade iron mining operation as soon as possible. The Company intends to take full advantage of the multi-user rail infrastructure currently being developed for the benefit of the Winning Consortium and the SimFer JV due for commissioning from late 2025.